Pasar al contenido principal

DISEÑO Y SINTESIS SOSTENIBLE DE NUEVOS COMPUESTOS ANTICANCER, ANTI-ALZHEIMER Y ANALGESICOS

PID2020-118303GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Improving Properties of Podophyllic Aldehyde-Derived Cyclolignans: Design, Synthesis and Evaluation of Novel Lignohydroquinones, Dual-Selective Hybrids against Colorectal Cancer Cells

  • Hernández, Ángela-Patricia
  • Díez, Paula
  • García, Pablo A.
  • Pérez-Andrés, Martin
  • Veselinova, Anzhela
  • Jambrina, Pablo G.
  • San Feliciano, Arturo
  • Díez, David
  • Fuentes, Manuel
  • Castro, M. Ángeles
New lignohydroquinone conjugates (L-HQs) were designed and synthesized using the hybridization strategy, and evaluated as cytotoxics against several cancer cell lines. The L-HQs were obtained from the natural product podophyllotoxin and some semisynthetic terpenylnaphthohydroquinones, prepared from natural terpenoids. Both entities of the conjugates were connected through different aliphatic or aromatic linkers. Among the evaluated hybrids, the L-HQ with the aromatic spacer clearly displayed the in vitro dual cytotoxic effect derived from each starting component, retaining the selectivity and showing a high cytotoxicity at short (24 h) and long (72 h) incubation times (4.12 and 0.0450 µM, respectively) against colorectal cancer cells. In addition, the cell cycle blockade observed by flow cytometry studies, molecular dynamics, and tubulin interaction studies demonstrated the interest of this kind of hybrids, which docked adequately into the colchicine binding site of tubulin despite their large size. These results prove the validity of the hybridization strategy and encourage further research on non-lactonic cyclolignans., We gratefully acknowledge Grants PID2020-118303GB-I00 and PID2020-113147GA-I00 funded by MCIN/AEI/10.13039/501100011033. We also acknowledge Junta de Castilla y Leoń (for the grant SA076P20); USAL (for the Financiación GIR PRONABIOLACT and C1 program 18.K199/463AC01); Spanish Health Institute Carlos III (ISCIII) for the grants: FIS PI17/01930, PI21/01545, and CB16/12/00400. The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17/0019/0023, of the PE I + D + I 2017-2020, funded by ISCIII and FEDER. This research work was funded by the European Commission—NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global). A.V. acknowledges Grant No. EDU/1508/2020 (Junta Castilla y León and European Social Fund).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan

  • García, Pablo A.
  • Hernández, Ángela-Patricia
  • Gómez-Zurita, Mª Antonia
  • Miguel del Corral, José M.
  • Gordaliza, Marina
  • Francesch, Andrés
  • San Feliciano, Arturo
  • Castro, M. Ángeles
Podophyllotoxin, a cyclolignan natural product, has been the object of extensive chemomodulation to obtain better chemotherapeutic agents. Among the obtained podophyllotoxin derivatives, podophyllic aldehyde showed very interesting potency and selectivity against several tumoral cell lines, so it became our lead compound for further modifications, as described in this work, oriented toward the enlargement of the cyclolignan skeleton. Thus, modifications performed at the aldehyde function included nucleophilic addition reactions and the incorporation of the aldehyde carbon into several five-membered rings, such as thiazolidinones and benzo-fused azoles. The synthesized derivatives were evaluated against several types of cancer cells, and although some compounds were cytotoxic at the nanomolar range, most of them were less potent and less selective than the parent compound podophyllic aldehyde, with the most potent being those having the lactone ring of podophyllotoxin. In silico ADME evaluation predicted good druggability for most of them. The results indicate that the γ-lactone ring is important for potency, while the α,β-unsaturated aldehyde is necessary to induce selectivity in these cyclolignans., This research was funded by Spanish MCIN/AEI/10.13039/501100011033 (Project PID2020-118303G-I00) and by the Junta de Castilla y León, co-funded by the European Social Fund (Project SA076P20)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Podophyllic Aldehyde, a Podophyllotoxin Derivate, Elicits Different Cell Cycle Profiles Depending on the Tumor Cell Line: A Systematic Proteomic Analysis

  • Hernández, Ángela-Patricia
  • Chaparro-González, Lorea
  • Garzo-Sánchez, Olga
  • Arias-Hidalgo, Carlota
  • Juanes-Velasco, Pablo
  • García, Pablo A.
  • Castro, M. Ángeles
  • Fuentes, Manuel
When new antitumor therapy drugs are discovered, it is essential to address new target molecules from the point of view of chemical structure and to carry out efficient and systematic evaluation. In the case of natural products and derived compounds, it is of special importance to investigate chemomodulation to further explore antitumoral pharmacological activities. In this work, the compound podophyllic aldehyde, a cyclolignan derived from the chemomodulation of the natural product podophyllotoxin, has been evaluated for its viability, influence on the cell cycle, and effects on intracellular signaling. We used functional proteomics characterization for the evaluation. Compared with the FDA-approved drug etoposide (another podophyllotoxin derivative), we found interesting results regarding the cytotoxicity of podophyllic aldehyde. In addition, we were able to observe the effect of mitotic arrest in the treated cells. The use of podophyllic aldehyde resulted in increased cytotoxicity in solid tumor cell lines, compared to etoposide, and blocked the cycle more successfully than etoposide. High-throughput analysis of the deregulated proteins revealed a selective antimitotic mechanism of action of podophyllic aldehyde in the HT-29 cell line, in contrast with other solid and hematological tumor lines. Also, the apoptotic profile of podophyllic aldehyde was deciphered. The cell death mechanism is activated independently of the cell cycle profile. The results of these targeted analyses have also shown a significant response to the signaling of kinases, key proteins involved in signaling cascades for cell proliferation or metastasis. Thanks to this comprehensive analysis of podophyllic aldehyde, remarkable cytotoxic, antimitotic, and other antitumoral features have been discovered that will repurpose this compound for further chemical transformations and antitumoral analysis., This study was funded by Instituto de Salud Carlos III (ISCIII) through the projects PI21/01545 and CB16/12/00400 and was co-funded by the European Union. We also acknowledge Fondos FEDER (EU) and Junta Castilla-León (COVID-19 grant COV20EDU/00187). The Proteomics Unit belongs to ProteoRed, PRB3-ISCIII, supported by grant PT17/0019/0023, of the PE I + D + I 2017–2020, funded by ISCIII and FEDER. This research work was funded by the European Commission NextGenerationEU, through CSIC’s Global Health Platform (PTI + Salud Global, SGL2103027). University of Salamanca was supported by the C1 program 18.K199. We gratefully acknowledge financial support from the Spanish MINECO (PID2020-118303GB-I00). We also acknowledge Conexion NanoMedicina CSIC-Hub for support. CA-H is supported by JCYL Program and Fondo Social Europeo (FSE+) scholarship EDU-1868-2022, and by Health Institute Carlos III (ISCIII) and Institute of Biomedical Research of Salamanca (IBSAL) scholarship FI22/0000323. PJV is supported by the JCYL PhD Program “Nos Impulsa-JCYL” and scholarship JCYL-EDU/601/2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Insights into podophyllotoxin lactone features: New cyclolignans as potential dual tubulin-topoisomerase II inhibitors

  • Hernández, Ángela-Patricia
  • Rosales-Fernández, Celia
  • Miranda-Vera, Carolina
  • Veselinova, Anzhela
  • Jambrina, Pablo G.
  • García-García, Pilar
  • García, Pablo A.
  • Díez, David
  • Castro, M. Ángeles
  • Fuentes, Manuel
Chemomodulation of natural cyclolignans as podophyllotoxin has been a successful approach to obtain semisynthetic bioactive derivates. One example of this approach is the FDA-approved drug etoposide for solid and hematological tumors. It differs from the antimitotic activity of the natural product in its mechanism of action, this drug being a topoisomerase II inhibitor instead of a tubulin antimitotic. Within the molecular requirements for the activity of these compounds, the trans-γ-lactone moiety presented in the parent compound has always been a feature to be explored to chemomodulate its bioactivity. In this study, we have obtained different compounds that comply with the molecular characteristics for antitubulin and antitopoisomerase II activity combined in a single molecule. Furthermore, we explored the influence of the trans-lactone moiety on the final activity, finding that the cis-lactone was also interesting in terms of bioactivity. The best values of cytotoxicity and cell cycle inhibition were obtained for a compound lacking the lactone ring, thus mimicking the podophyllic aldehyde functionalization, a selective antimitotic podophyllotoxin derivate. The analogs with cis-lactone also presented interesting cytotoxic activity. The present study illustrates the potential of the chemomodulation of natural products such as natural cyclolignan podophyllotoxin derivates for the discovery of new antitumor agents., We gratefully acknowledge financial support from the Spanish MICIN (PID2020-118303GB-I00, MCIN/AEI/10.13039/501100011033) and Junta de Castilla y León (SA076P20). Ángela-Patricia Hernández acknowledges the University of Salamanca supported by C1 program 18.K199 and C2 program K240-463AC01. Manuel Fuentes acknowledges Institute de Salud Carlos III (ISCIII) through the projects PI21/01545 and CB16/12/00400 and co-funded by the European Union. This research study was funded by the European Commission NextGenerationEU, through CSIC's Global Health Platform (PTI + Salud Global, SGL2103027). Pablo G. Jambrina acknowledges grant PID2020-113147GA-I00 by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/MCIN/AEI/10.13039/501100011033). Anzhela Veselinova acknowledges grant No. EDU/1508/2020 (Junta de Castilla y León and European Social Fond) Carolina Miranda-Vera acknowledges Junta de Castilla y León for the predoctoral fellowship co-funded by the European Social Fund (Orden EDU/842/2022)., Peer reviewed